The Fight Against Big Tobacco

Tobacco control leaders were extremely proud of the movement's achievements in the state of Minnesota. In sharing their perspectives and experiences with Mark Wolfson, they found a way of making sure that the story would get told. His training in social movements had given him an appreciation of the importance of understanding the social infrastructure on which movements are built, and Minnesota had built heavily on the infrastructure of health care and public health. What became apparent is that the struggle against the tobacco industry in Minnesota involved a close, collaborative relationship between government (or "state") actors and the leaders of the tobacco control movement. Wolfson develops both of these themes: building on the infrastructure of health, and state-movement interpenetration, to understand the emergence, growth, and outcomes of the tobacco control movement in Minnesota. He focuses on the advantages and constraints associated with these two related themes. He goes beyond the case study method to assess the generalizability of the pattern, and whether the same sort of movement can be used by other states in North America, and even in other countries and their social movements. How has the tobacco control movement become such a significant and successful force in shaping public policy, social norms, and the habits of millions of Americans? In this first such detailed study by a sociologist, Wolfson documents how the movement has grown over nearly three decades by building an infrastructure of health organizations and health professionals, and by fostering relationships with government. Rich in survey data, extensive interviews, and archival sources, this text is essential reading for courses in social problems, social movements, and public health. The general reader will also find it engaging, given the issues of tobacco use as an addiction and a social problem.

The cigarette is the deadliest artifact in the history of human civilization. It is also one of the most beguiling, thanks to more than a century of manipulation at the hands of tobacco industry chemists. In Golden Holocaust, Robert N. Proctor draws on reams of formerly-secret industry documents to explore how the cigarette came to be the most widely-used drug on the planet, with six trillion sticks sold per year. He paints a harrowing picture of tobacco manufacturers conspiring to block the recognition of tobacco-cancer hazards, even as they ensnare legions of scientists and politicians in a web of denial. Proctor tells heretofore untold stories of fraud and subterfuge, and he makes the strongest case to date for a simple yet ambitious remedy: a ban on the manufacture and sale of cigarettes.

The U.S. scientific community has long led the world in research on such areas as public health, environmental science, and issues affecting quality of life. These scientists have produced landmark studies on the dangers of DDT, tobacco smoke, acid rain, and global warming. But at the same time, a small yet potent subset of this community leads the world in vehement denial of these dangers. Merchants of Doubt tells the story of how a loose-knit group of high-level scientists and scientific advisers, with deep connections in politics and industry, ran effective campaigns to mislead the public and deny well-established scientific knowledge over four decades. Remarkably, the same individuals surface repeatedly-some of the same figures who have claimed that the science of global warming is "not settled" denied the truth of studies linking smoking to lung cancer, coal smoke to acid rain, and CFCs to the ozone hole. "Doubt is our product," wrote one tobacco executive. These "experts" supplied it. Naomi Oreskes and Erik M. Conway, historians of science, roll back the rug on this dark corner of the American scientific community, showing how ideology and corporate interests, aided by a too-compliant media, have skewed public understanding of some of the most pressing issues of our era.

The story of tobacco’s fortunes seems simple: science triumphed over addiction and profit. Yet the reality is more complicated—and more political. Historically it was not just bad habits but also the state that lifted the tobacco industry. What brought about change was not medical advice but organized pressure: a movement for nonsmoker’s rights.

Despite overwhelming evidence of tobacco's harmful effects and pressure from anti-smoking advocates, current surveys show that about one-quarter of all adults in the United States are smokers. This audience is the target for a wave of tobacco products and pharmaceuticals that claim to preserve tobacco pleasure while reducing its toxic effects. Clearing the Smoke addresses the problems in evaluating whether such products actually do reduce the health risks of tobacco use. Within the context of regulating such products, the committee explores key questions: Does the use of such products decrease exposure to harmful substances in tobacco? Is decreased exposure associated with decreased harm to health? Are there surrogate indicators of harm that could be measured quickly enough for regulation of these products? What are the public health implications? This book looks at the types of products that could reduce harm and reviews the available evidence for their impact on various forms of cancer and other major ailments. It also recommends approaches to governing these products and tracking their public health effects. With an attitude of healthy skepticism, Clearing the Smoke will be important to health policy makers, public health officials, medical practitioners, manufacturers and marketers of "reduced-harm" tobacco products, and anyone trying to sort through product claims.

These documents provide a shocking inside account of the activities of one tobacco company, Brown & Williamson, and its multinational parent, British American Tobacco, over more than thirty years.

NEW YORK TIMES EDITORS’ CHOICE • Big Tobacco meets Silicon Valley in this “deeply reported and illuminating” (The New York Times Book Review) corporate exposé of what happened when two of the most notorious industries collided—and the vaping epidemic was born. “The best business book I’ve read since Bad Blood.”—Jonathan Eig, New York Times bestselling author of Ali: A Life Howard Willard lusted after Juul. As the CEO of tobacco giant Philip Morris’s parent company and a veteran of the industry’s long fight to avoid being regulated out of existence, he grew obsessed with a prize he believed could save his company—the e-cigarette, a product with all the addictive upside of the original without the same apparent health risks and bad press. Meanwhile, in Silicon Valley, Adam Bowen and James Monsees began working on a device that was meant to save lives and destroy Big Tobacco, but they ended up baking the industry’s DNA into their invention’s science and marketing. Ultimately, Juul’s e-cigarette was so effective and so market-dominating that it put the company on a collision course with Philip Morris and sparked one of the most explosive public health crises in recent memory. In a deeply reported account, award-winning journalist Lauren Etter tells a riveting story of greed and deception in one of the biggest botched deals in business history. Etter shows how Philip Morris’s struggle to innovate left Willard desperate to acquire Juul, even as his own team sounded alarms about the startup’s reliance on underage customers. And she shows how Juul’s executives negotiated a lavish deal that let them pocket the lion’s share of Philip Morris’s $12.8 billion investment while government regulators and furious parents mounted a campaign to hold the company’s feet to the fire. The Devil’s Playbook is the inside story of how Juul’s embodiment of Silicon Valley’s “move fast and break things” ethos wrought havoc on American health, and how a beleaguered tobacco company was seduced by the promise of a new generation of addicted customers. With both companies’ eyes on the financial prize, neither anticipated the sudden outbreak of vaping-linked deaths that would terrorize a nation, crater Juul’s value, end Willard’s career, and show the costs in human life of the rush to riches—while Juul’s founders, board members, and employees walked away with a windfall.